Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver-related mortality in patients with diabetes,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver-related mortality in patients with diabetes
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-09-10 , DOI: 10.1111/apt.18254
Xianhua Mao _{1,

2} , Ka-Shing Cheung _{1,

2} , Jing-Tong Tan ₁ , Lung-Yi Mak _{1,

3} , Chi-Ho Lee ₁ , Chi-Leung Chiang ₄ , Ho-Ming Cheng ₁ , Rex Wan-Hin Hui ₁ , Wai K Leung ₁ , Man-Fung Yuen _{1,

3} , Wai-Kay Seto _{1,

2,

3}

Affiliation

Optimal glycaemic control has well-established health benefits in patients with diabetes mellitus (DM). It is uncertain whether optimal glycaemic control can benefit liver-related outcomes.

中文翻译：